Results 91 to 100 of about 6,853,945 (355)

Role of a clinical pharmacist in managing diabetic nephropathy: an approach of pharmaceutical care plan [PDF]

, 2015
Amer Khan Mohammed, Chaitanya Medarametla, Mohammed Mahboob E. Rabbani, Kolamadhi Prashanthi   +3 more
openalex   +1 more source

Stroke Epidemics', The Neurological Emergency of Concern in South-West, Nigeria, W/Africa: The Burden, Pre-Hospital Care Quality, Patterns of Presentations and Treatment Outcomes of Stroke Patients Managed in a Nigerian Tertiary Health Facility, W/Africa

, 2022
Idowu EO, Adeniji FIP, Jonathan A. Edlow, David Chiu   +3 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States

Human Vaccines & Immunotherapeutics, 2017
Few peer-reviewed publications present real-world United States (US) data describing resource utilization and costs associated with herpes zoster (HZ) and postherpetic neuralgia (PHN).
Juliana L. Meyers, Shweta Madhwani, Debora Rausch, Sean D. Candrilli, Girishanthy Krishnarajah, Songkai Yan   +5 more
doaj   +1 more source

Potential drug–drug interactions when managing status epilepticus patients in intensive care: A cohort study [PDF]

, 2021
Clémentine Le Roux, Alexandre Destère, Sarah Hervy, Célia Lloret‐Linares, Jean Reignier, Pascal Caillet, Pascale Jolliet, Bruno Mégarbane, D. Boels   +8 more
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Welcome note ICIC13 organizing committee

International Journal of Integrated Care, 2013
Volker Amelung
doaj   +3 more sources

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

The impact of non-medical switching among ambulatory patients: an updated systematic literature review

Journal of Market Access & Health Policy, 2019
Background: Non-medical switching (NMS) is defined as switching to a clinically similar but chemically distinct medication for reasons apart from lack of effectiveness, tolerability or adherence.
Erin R. Weeda, Elaine Nguyen, Silas Martin, Michael Ingham, Diana M. Sobieraj, Brahim K. Bookhart, Craig I. Coleman   +6 more
doaj   +1 more source